CVE:CZO Ceapro (CZO) Stock Price, News & Analysis → Beta testers blew this thing up (From Prosper Trading Academy) (Ad) Free CZO Stock Alerts C$0.22 -0.03 (-11.76%) (As of 05/31/2024) Add Compare Share Share Today's RangeC$0.23▼C$0.2450-Day RangeC$0.23▼C$0.3052-Week RangeC$0.15▼C$0.54Volume5,849 shsAverage Volume50,562 shsMarket CapitalizationC$17.62 millionP/E RatioN/ADividend Yield1.80%Price TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Get Ceapro alerts: Email Address Ad Behind the MarketsBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.Get the full story here >>> About Ceapro Stock (CVE:CZO)Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.Read More CZO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CZO Stock News HeadlinesMarch 12, 2024 | nz.finance.yahoo.comUniversal Music Restructuring Continues, East Coast Labels Unite via Republic Corps DivisionMarch 12, 2024 | nz.finance.yahoo.comA Complete Breakdown of Kate Middleton's Photoshop ControversyJune 18, 2024 | Prosper Trading Academy (Ad)Beta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)December 14, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - CZODecember 14, 2023 | finance.yahoo.comAeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyNovember 29, 2023 | finance.yahoo.comCeapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational HighlightsNovember 27, 2023 | nz.finance.yahoo.comPSA: Charlotte Tilbury's Mystery Box is back, and there's a huge surprise in storeNovember 27, 2023 | finance.yahoo.comCeapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based DiseasesJune 18, 2024 | Prosper Trading Academy (Ad)Beta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)September 14, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc flat on Wednesday (CZO)September 6, 2023 | ca.finance.yahoo.comCeapro Inc. (CZO.V)August 3, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Wednesday (CZO)July 30, 2023 | finance.yahoo.comAre Ceapro Inc.'s (CVE:CZO) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?July 19, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Wednesday (CZO)May 25, 2023 | stockhouse.comCeapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate UpdateMay 13, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Friday (CZO)May 3, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Tuesday (CZO)May 3, 2023 | finance.yahoo.comCeapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue RegenerationApril 22, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Friday (CZO)April 21, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Thursday (CZO)April 19, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Tuesday (CZO)April 12, 2023 | finance.yahoo.comCeapro Inc. Reports Record 2022 Financial Results and Operational HighlightsApril 11, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Monday (CZO)April 6, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc flat on Thursday (CZO)February 20, 2023 | finance.yahoo.comIs Weakness In Ceapro Inc. (CVE:CZO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?November 11, 2022 | uk.finance.yahoo.comReturns At Ceapro (CVE:CZO) Are On The Way UpOctober 13, 2022 | finance.yahoo.comCeapro Inc. Announces Positive Data from Bioavailability Studies Evaluating CoQ10 Formulations Impregnated with PGX-Processed CarriersSee More Headlines Receive CZO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/29/2024Today6/18/2024Next Earnings (Estimated)9/03/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:CZO CUSIPN/A CIKN/A Webwww.ceapro.com Phone+1-780-4214555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.06) Trailing P/E RatioN/A Forward P/E Ratio5.63 P/E GrowthN/ANet IncomeC$-4,710,000.00 Net Margins-48.89% Pretax MarginN/A Return on Equity-15.66% Return on Assets-11.30% Debt Debt-to-Equity Ratio8.07 Current Ratio8.54 Quick Ratio18.88 Sales & Book Value Annual SalesC$9.63 million Price / Sales1.83 Cash FlowC$0.06 per share Price / Cash Flow3.94 Book ValueC$0.36 per share Price / Book0.63Miscellaneous Outstanding Shares78,290,000Free FloatN/AMarket CapC$17.62 million OptionableNot Optionable Beta1.38 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Gilles R. Gagnon ICD.D (Age 70)M.B.A., M.Sc., CEO, President & Director Comp: $560kMs. Stacy Prefontaine C.A.CPA, CA, CPA, CFO & Corporate SecretaryDr. Bernhard SeifriedSenior Director of Research & TechnologyMr. Michel Regnier P. Eng.Senior Vice President of Technical OperationsKey CompetitorsPediapharmCVE:PDPHelix BioPharmaTSE:HBPEmerald Health TherapeuticsCVE:EMHProMIS NeurosciencesTSE:PMNSmall PharmaCVE:DMTView All Competitors CZO Stock Analysis - Frequently Asked Questions How have CZO shares performed in 2024? Ceapro's stock was trading at C$0.19 at the beginning of 2024. Since then, CZO shares have increased by 18.4% and is now trading at C$0.23. View the best growth stocks for 2024 here. When is Ceapro's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 3rd 2024. View our CZO earnings forecast. How were Ceapro's earnings last quarter? Ceapro Inc. (CVE:CZO) issued its quarterly earnings data on Monday, April, 29th. The company reported ($0.03) earnings per share (EPS) for the quarter. The business earned $1.65 million during the quarter. Ceapro had a negative net margin of 48.89% and a negative trailing twelve-month return on equity of 15.66%. What other stocks do shareholders of Ceapro own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ceapro investors own include Franco-Nevada (FNV), Badger Daylighting (BAD), FLYHT Aerospace Solutions (FLY), Invesco Water Resources ETF (PHO), Russel Metals (RUS), ServisFirst Bancshares (SFBS), Chemtrade Logistics Income Fund (CHE.UN), Bausch Health Companies (BHC), BCE (BCE) and BlackBerry (BB). How do I buy shares of Ceapro? Shares of CZO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:CZO) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ceapro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ceapro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.